Literature DB >> 31836027

Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

Sandhya R Panch, Bipin N Savani, David F Stroncek.   

Abstract

Entities:  

Year:  2019        PMID： 31836027      PMCID： PMC6917036          DOI： 10.1053/j.seminhematol.2019.11.007

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  38 in total

1.  RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.

Authors:  Ross M Fasano; Alessandro Monaco; Emily Riehm Meier; Philippe Pary; A Hallie Lee-Stroka; John Otridge; Harvey G Klein; Francesco M Marincola; Naynesh R Kamani; Naomi L C Luban; David Stroncek; Willy A Flegel
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Alloimmunization in sickle cell anemia in the era of extended red cell typing.

Authors:  Chibuzo O'Suoji; Robert I Liem; A Kyle Mack; Paris Kingsberry; Glenn Ramsey; Alexis A Thompson
Journal:  Pediatr Blood Cancer       Date:  2013-03-18       Impact factor: 3.167

3.  Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.

Authors:  Y Lin; A Saskin; R A Wells; M Lenis; A Mamedov; J Callum; R Buckstein
Journal:  Vox Sang       Date:  2016-10-19       Impact factor: 2.144

4.  Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Authors:  E P Vichinsky; N L Luban; E Wright; N Olivieri; C Driscoll; C H Pegelow; R J Adams
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

Review 5.  Understanding red blood cell alloimmunization triggers.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

Authors:  Dorothea Evers; Rutger A Middelburg; Masja de Haas; Saurabh Zalpuri; Karen M K de Vooght; Daan van de Kerkhof; Otto Visser; Nathalie C Péquériaux; Francisca Hudig; Henk Schonewille; Jaap Jan Zwaginga; Johanna G van der Bom
Journal:  Lancet Haematol       Date:  2016-05-09       Impact factor: 18.959

Review 7.  Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Hematol Oncol Clin North Am       Date:  2016-06       Impact factor: 3.722

8.  Immunohaematological complications in patients with sickle cell disease after haemopoietic progenitor cell transplantation: a prospective, single-centre, observational study.

Authors:  Elizabeth S Allen; Kshitij Srivastava; Matthew M Hsieh; Courtney D Fitzhugh; Harvey G Klein; John F Tisdale; Willy A Flegel
Journal:  Lancet Haematol       Date:  2017-11       Impact factor: 18.959

9.  Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.

Authors:  Santosh L Saraf; Annie L Oh; Pritesh R Patel; Yash Jalundhwala; Karen Sweiss; Matthew Koshy; Sally Campbell-Lee; Michel Gowhari; Johara Hassan; David Peace; John G Quigley; Irum Khan; Robert E Molokie; Lewis L Hsu; Nadim Mahmud; Dennis J Levinson; A Simon Pickard; Joe G N Garcia; Victor R Gordeuk; Damiano Rondelli
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-05       Impact factor: 5.742

10.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.